Technology designed to aid on-the-field diagnostics for military applications is gaining a wider reach as Lawrence Livermore National Laboratory (LLNL) and BioVind, LLC achieved a milestone in their partnership: the exclusive licensing of LLNL pathogen diagnostics technology focused on oil and gas applications.
The technology, called BioID, is a rapid and portable molecular diagnostics platform that can detect up to 18 target DNA or RNA sequences from a single sample in 30 to 60 minutes. BioID uses an isothermal amplification technique to detect pathogen nucleic acid.